Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 177 M187 M184 M259 M 807 M Research & development ———— — Operating income 260 M305 M340 M96 M 1 B Non-Operating Income, Total -15 M01 M1 M -13 M Interest expense, net of interest capitalized 25 M26 M26 M26 M 103 M Non-Operating Income, excl. Interest Expenses -40 M-26 M-25 M-25 M -116 M Unusual income/expense ———— — Pretax income 220 M279 M315 M71 M 885 M Equity in earnings 003 M— — Taxes 50 M55 M48 M17 M 170 M Non-controlling/minority interest ———— — After tax other income/expense -3 M-1 M7 M-2 M 1 M Net income before discontinued operations 170 M224 M267 M54 M 715 M Discontinued operations ———— — Net income 170 M224 M267 M54 M 715 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 170 M224 M267 M54 M 715 M Basic earnings per share (Basic EPS) 0.360.470.580.12 1.53 Diluted earnings per share (Diluted EPS) 0.360.470.580.12 1.53 Average basic shares outstanding 472.72 M471.87 M462.46 M466.33 M — Diluted shares outstanding 472.96 M472.61 M462.86 M466.73 M — EBITDA ———— — EBIT 398 M463 M493 M137 M 1.49 B Cost of revenue 372 M421 M416 M341 M 1.55 B Other cost of goods sold 267 M300 M340 M247 M 1.15 B Depreciation & amortization (cash flow) ———— —